Collaborate Disseminate
The World Health Organization’s (WHO) cancer research agency has delivered a damning report on powdered mineral talc, calling it “probably” cancer-causing to humans, mainly because of powders being unknowingly contaminated with asbestos.Continue Readin… Continue reading Talc “probably” causes cancer, WHO agency finds
High-grade serous ovarian cancer is not only common but an aggressive, hard-to-treat type of ovarian cancer. A new study has identified the genes involved in forming a particular type of lymphatic tissue which, if growing in tumors, is associated with … Continue reading Genes identified that may lead to treatment for aggressive ovarian cancer
Despite treatment, the survival rates for women with ovarian cancer remain poor, and the chance of the cancer returning is high. But there could be hope for women whose cancer has returned following chemotherapy in the form of a promising cancer-fighti… Continue reading Promising ovarian cancer drug in phase 3 clinical trials
Ovarian cancer is the fifth biggest cause of cancer death in women, and part of its frustrating stubbornness to treat and high level of recurrence may be down to some surprisingly cellular cooperation.Continue ReadingCategory: Medical, ScienceTags: Can… Continue reading Ovarian cancer cells resist chemo and strengthen neighbors to survive
Ovarian cancer is a highly fatal type of cancer that can be caused by several genetic factors. A recent study examined whether the protection provided by taking aspirin frequently, which has been shown to reduce ovarian cancer risk, was affected by a g… Continue reading Aspirin reduces ovarian cancer risk regardless of genetic predisposition
Researchers at the University of Pennsylvania have developed an electronic nose (or e-nose) that may be able to sniff out signs of cancer from blood plasma samples. In tests, the device was able to detect a range of cancer types with over 90 percent ac… Continue reading Electronic nose sniffs out cancer in blood samples with over 90% accuracy
“Synthetic lethality” is a phenomenon where genetic mutations that normally don’t harm a cell suddenly become deadly when paired up. Now, scientists have found a way to use this method to selectively kill off cancer that results from genetic mutations,… Continue reading “Synthetic lethality” kills cancer by blocking DNA repair mechanism
Preliminary results from a small human trial testing a novel cancer drug revealed over half the cohort had their tumors stop growing completely. The experimental drug, called berzosertib, is moving to larger clinical trials with experts expressing caut… Continue reading New class of cancer drug halts tumor growth in early human trials
A new study has shown that an experimental class of cancer drugs has wider potential than previously thought. BET inhibitors are currently being tested against blood cancers, but now researchers have found a new version of this drug that, in mouse test… Continue reading Experimental cancer drug appears more effective, less toxic than others
Cancer cells often deploy specific “don’t eat me” signals to hide from immune cells. A breakthrough new study from Stanford University has homed in on a previously undiscovered signaling protein that, if effectively inhibited, may lead to new treatments for breast, ovarian, and other difficult-to-treat cancers.
..
Continue Reading Breakthrough discovery of signal cancers use to hide from immune system
Category: Medical
Tags:
Continue reading Breakthrough discovery of signal cancers use to hide from immune system